Study Evaluating Enbrel (Etanercept) in Patients With Ankylosing Spondylitis

Observational Study With Enbrel (Etanercept) in Patients With Ankylosing Spondylitis

Status

Completed

Phases

Unknown

Study type

Observational

Source

ClinicalTrials.gov

Registry ID

NCT00227227

Enrollment

750

Registered

2005-09-27

Start date

2004-05-31

Completion date

2007-06-30

Last updated

2007-12-10

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ankylosing Spondylitis

Brief summary

The purpose of this study is to investigate the incidence of adverse events for patients with AS treated with Enbrel in usual care settings.

Interventions

None listed

Study design

Time perspective

PROSPECTIVE

Eligibility

Sex/Gender

ALL

Age

18 Years to No maximum

Healthy volunteers

Inclusion criteria

* Diagnosis of ankylosing spondylitis

Exclusion criteria

* Contraindications according SmPC

Countries

Germany

Outcome results